Theorem Clinical Research and Emergo Group have formed a strategic partnership to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics customers. Emergo Group offers a range of compliance and market access services in 25 countries and assists companies with global regulatory strategy, device registration, quality management system compliance, regulatory representation and distributor qualification.
 
“Emergo Group complements our own global strategic regulatory affairs and clinical trial capabilities,” said D. Lee Spurgin Jr., Ph.D., Theorem’s senior vice president and general manager of medical device and diagnostic development. “Working together we can provide more services and a bigger global footprint, so our strategic relationship helps us to be a one-stop provider for our clients.”
  
“The right strategic relationship strengthens both companies,” said Emergo Group president and chief executive officer Rene van de Zande. “We believe the synergy we achieve with Theorem is a benefit to all concerned.”